文献速递前列腺癌

PI-RADS v2 检测前列腺癌的阅片者间一致性:系统综述与荟萃分析

Interreader Agreement with Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Urol · 2020-06-18

该系统综述与荟萃分析检索2015年至2019年6月的文献,纳入30项研究共4095例患者,评估PI-RADS v2检测前列腺癌的阅片者间一致性。汇总κ值为0.61(95%CI 0.55-0.67),与v1头对头比较无显著差异;阅片者经验差异是研究异质性的唯一显著因素(p=0.01)。

要点

  • PI-RADS v2总体评分阅片者间一致性为中等偏强(汇总κ=0.61)。
  • 以评分≥4为阈值时一致性为中等偏强(κ=0.61),≥3为中等(κ=0.57)。
  • 移行区一致性(κ=0.49)低于外周带(κ=0.64)。

核心结论

  • PI-RADS v2在可疑前列腺癌患者总体评分中提供中等偏强的阅片者间一致性,与v1水平相似。
  • 阅片者经验差异是研究异质性的唯一显著影响因素(p=0.01)。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library(2015年至2019年6月3日)。
  • 纳入30项原始研究,共4095例患者,由2名独立评价者按GRRAS评估质量。
  • 计算PI-RADS v2的汇总κ值,对可用研究进行v1头对头比较,并按解剖分区、阈值和序列进行亚组分析及荟萃回归。

主要发现

  • PI-RADS v2汇总κ为0.61(95%CI 0.55-0.67)。
  • 4项头对头比较研究中,v1与v2的汇总κ相似(0.61,95%CI 0.33-0.90 vs 0.68,95%CI 0.57-0.79;p=0.61)。
  • 阈值≥4时κ=0.61,阈值≥3时κ=0.57;外周带κ=0.64,移行区κ=0.49。
  • 三个MRI序列(T2WI、DWI、DCE)的κ范围为0.42-0.58。

关键数值与推荐

  • PI-RADS v2总体评分汇总κ=0.61(95%CI 0.55-0.67)。
  • 头对头比较:v1汇总κ=0.61(95%CI 0.33-0.90),v2汇总κ=0.68(95%CI 0.57-0.79),p=0.61。
  • 亚组κ值:阈值≥4为0.61,阈值≥3为0.57;外周带0.64,移行区0.49;三个序列0.42-0.58。
  • 阅片者经验差异是研究异质性的唯一显著因素(p=0.01)。

临床怎么用

  • PI-RADS v2总体评分一致性中等偏强,可用于前列腺癌检测的结构化报告。
  • 移行区一致性低于外周带,判读时需注意。
  • 阅片者经验影响一致性,提示培训与经验积累对提高一致性有潜在价值。

局限性

  • 研究间异质性部分由阅片者经验差异解释(p=0.01),其他原因未完全明确。
  • 头对头比较v1与v2的研究仅4项,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated interreader agreement with PI-RADS® (Prostate Imaging Reporting and Data System) version 2 for detection of prostate cancer. MATERIALS AND METHODS: We searched MEDLINE®, Embase® and the Cochrane Library between 2015 and June 3, 2019 to identify original research reporting interreader agreement in the use of PI-RADS version 2. Quality of the retrieved studies was assessed by 2 independent reviewers using the Guidelines for Reporting Reliability and Agreement Studies. Pooled κ for PI-RADS version 2 was calculated, and a head-to-head comparison with version 1 was performed for the available studies. Subgroup analysis was performed according to zonal anatomy (peripheral or transitional zone), cutoff value (4 or higher, or 3 or higher) and specific imaging sequences (T2-weighted, diffusion-weighted and dynamic contrast enhanced). Meta-regression analysis was performed to assess the cause of study heterogeneity. RESULTS: A total of 30 studies (4,095 patients) were included. Pooled κ of PI-RADS version 2 was 0.61 (95% CI 0.55-0.67). In 4 studies evaluating head-to-head comparisons PI-RADS versions 1 and 2 showed similar pooled κ values (0.61, 95% CI 0.33-0.90 vs 0.68, 95% CI 0.57-0.79; p=0.61). Substantial interreader agreement was noted with a cutoff of 4 or higher (κ=0.61) and moderate agreement was observed with a cutoff of 3 or higher (κ=0.57), peripheral zone (κ=0.64), transitional zone (κ=0.49) and the 3 magnetic resonance imaging sequences (κ 0.42-0.58). Difference in reader experience was the single significant factor affecting study heterogeneity (p=0.01). CONCLUSIONS: PI-RADS version 2 provides substantial interreader agreement in overall scoring in patients with suspicious prostate cancer, with a similar level of agreement to version 1.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Park KJ, Choi SH, Lee JS, et al. Interreader Agreement with Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection: A Systematic Review and Meta-Analysis. J Urol. 2020. PMID: 32552474. doi:10.1097/JU.0000000000001200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。